0:00 Introduction
0:30 What inspired you to get involved with BrightEdge and how does one go about doing that?
1:52 How do you think that impact investing is going to like advanced venture capital or private capital markets? Or how will it add to private capital markets?
08:21 What are you currently learning or listening to or reading these days?
10:41 In 2 years, how do you see Artificial Intelligence impacting your industry?
11:27 How do people contact you?
11:53 Thank you

Alice Pomponio is Vice President of Innovation and Impact Investing at American Cancer Society and Managing Director of BrightEdge —ACS’s mission-driven venture capital and impact investment arm. She’s an impact investor, social innovation entrepreneur, and patient advocate with extensive experience in life sciences and business and passion for health equity.

BrightEdge exists to accelerate the American Cancer Society's goal to reduce cancer mortality, end pain and suffering, and advance health equity. As their donor-funded impact venture capital fund, BrightEdge invests alongside top-tier life sciences and healthcare investors in for-profit companies developing therapeutics, diagnostics, medical devices, and technologies to eradicate cancer.